A Step Change in the MenaQ7® Portfolio
Amidst the hustle and bustle of SupplySide West, the Gnosis team was excited to unveil our latest portfolio development – a turnkey immune product designed to bolster one’s foundational health, in a dose form that is meant to seamlessly support the fast-moving, quality-driven consumer. The product is a result of the successful partnership between Gnosis and Probiotcal.
This launch marks a significant milestone in the MenaQ7® journey: introducing a ready-to-market private label finished product. This step change presents brand owners with clear advantages, enabling them to bypass the often-time-consuming development phase and proceed directly to product launch. They can do so with the assurance that they are offering a science backed, branded ingredient in a well-formulated supplement, perfectly positioned for a targeted audience. The launch is a true testament to one of our guiding pillars: Come for K2 Science, Stay for the Partnership.